Drug Approval | October 05, 2023
Alembic received 6 USFDA approvals during Q2FY24
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Subscribe To Our Newsletter & Stay Updated
